Unknown

Dataset Information

Recent advances in targeting protein arginine methyltransferase enzymes in cancer therapy.


ABSTRACT:

Introduction

Exploration in the field of epigenetics has revealed the diverse roles of the protein arginine methyltransferase (PRMT) family of proteins in multiple disease states. These findings have led to the development of specific inhibitors and discovery of several new classes of drugs with potential to treat both benign and malignant conditions. Areas covered: We provide an overview on the role of PRMT enzymes in healthy and malignant cells, highlighting the role of arginine methylation in specific pathways relevant to cancer pathogenesis. Additionally, we describe structure and catalytic activity of PRMT and discuss the mechanisms of action of novel small molecule inhibitors of specific members of the arginine methyltransferase family. Expert opinion: As the field of PRMT bi

SUBMITTER: Smith E 

PROVIDER: S-EPMC6311705 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature